Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-10

FDA Approved: RETIN-A MICRO — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for RETIN-A MICRO (tretinoin) submitted by Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RETIN-A MICRO (TRETINOIN)

Snippet

SUPPL AP for RETIN-A MICRO (TRETINOIN)